CONDITION

Chronic Kidney Disease in Dogs

A progressive decline in kidney function that affects waste filtration, hydration, and metabolic balance over months to years.

Why this matters now

Chronic kidney disease is one of the more commonly diagnosed conditions in older dogs, though it tends to receive less attention than its feline counterpart. The prevalence increases with age, particularly in dogs over seven years, though certain breeds including Cavalier King Charles Spaniels, Bull Terriers, English Cocker Spaniels, and Shar Peis may have a predisposition to earlier onset. Unlike in cats, where the cause is frequently undetermined, canine CKD may sometimes be traced to specific causes including congenital kidney abnormalities, previous infections (such as leptospirosis), toxic exposures, dental disease with chronic bacteraemia, or immune-mediated conditions.

The progression of CKD in dogs is generally gradual but can vary significantly between individuals. Some dogs remain stable for months to years with appropriate management, while others experience a more rapid decline. The course is often characterised by a slow escalation of drinking and urination, subtle changes in appetite and body condition, and periodic episodes of feeling unwell that may resolve with supportive care. Unlike acute kidney injury, which may be reversible, the nephron loss in chronic kidney disease is permanent and cumulative, though the rate of progression can be influenced by management strategies.

Signals & patterns

Early signals

Increased water consumption and urination

As the kidneys lose their ability to concentrate urine, dogs produce larger volumes of dilute urine and drink more to compensate. This polyuria and polydipsia may initially be subtle, with slightly more frequent requests to go outside or a water bowl that needs refilling more often. In some dogs, the change is gradual enough to go unnoticed until it becomes quite pronounced. Overnight urination in a previously reliable dog can be an early indicator of this loss of concentrating ability.

Mild appetite changes

Early kidney disease may cause subtle fluctuations in appetite. Dogs may eat slightly less than usual, become more selective about food, or occasionally skip meals. As waste products begin to accumulate in the blood, low-grade nausea can affect food interest. These changes may be intermittent and easily attributed to normal variation in appetite rather than an underlying condition.

Gradual weight loss

A slow reduction in body condition may develop as the condition progresses. This can involve loss of muscle mass, particularly over the spine and hindquarters, as well as reduced fat reserves. The change may be so gradual that it is first noticed during a veterinary examination or by someone who has not seen the dog for some time. Regular weight monitoring can help identify trends that might otherwise be overlooked.

Reduced energy levels

Dogs may become less enthusiastic about activities they previously enjoyed, tire more quickly on walks, or rest more during the day. This reduced vitality can reflect the metabolic impact of accumulating waste products, developing anaemia, or simply feeling generally below par. As with many early signs, the gradual nature of the change often leads to attribution to ageing rather than a developing condition.

Later signals

Vomiting and gastrointestinal signs

As uraemic toxins accumulate to higher levels, nausea and vomiting may become more frequent and persistent. Dogs may develop a dull appetite with occasional vomiting, particularly in the morning or on an empty stomach. The accumulation of uraemic toxins can cause irritation of the gastrointestinal lining, leading to nausea, inappetence, and sometimes diarrhoea. These signs often fluctuate in severity and may temporarily improve with supportive care.

Oral changes

Dogs with advancing CKD may develop uraemic breath, a distinctive unpleasant odour caused by the breakdown of urea to ammonia in the saliva. Oral ulceration, particularly on the gums, tongue, and inner cheeks, can develop as uraemic toxins damage the oral mucosa. These oral changes may cause pain on eating and further contribute to appetite reduction. Brownish discolouration of the tongue can sometimes be observed.

Dehydration despite increased drinking

Despite consuming large volumes of water, dogs may become progressively dehydrated as the kidneys' inability to retain fluid outpaces their compensatory drinking. Signs of dehydration include dry, tacky gums, reduced skin elasticity, and sunken eyes. This chronic sub-clinical dehydration can further impair kidney function and contribute to episodes of acute deterioration.

Weakness and pallor

As kidney disease progresses, reduced erythropoietin production can lead to anaemia, manifesting as pale gums, reduced exercise tolerance, and general weakness. The anaemia tends to develop gradually and may be quite advanced before it becomes clinically apparent. Combined with the effects of uraemia and dehydration, anaemia can significantly impact the dog's overall vitality and quality of life.

Click to read about the biological mechanisms

How this is usually investigated

Investigation of chronic kidney disease in dogs typically involves a staged approach combining blood work, urinalysis, blood pressure assessment, and imaging. The goal is not only to confirm the presence of kidney disease but also to determine its stage, identify any underlying or contributing causes, and detect complications that may require specific management.

Blood biochemistry and SDMA

Purpose: Measurement of serum creatinine, blood urea nitrogen (BUN), and symmetric dimethylarginine (SDMA) provides the primary biochemical assessment of kidney function. SDMA is a relatively newer marker that may increase earlier than creatinine in the course of kidney disease, potentially allowing earlier detection. Concurrent assessment of phosphorus, calcium, potassium, and albumin levels helps characterise the metabolic impact of the disease and guide management.
Considerations: Creatinine is influenced by muscle mass, meaning muscular dogs may have higher baseline values while dogs with significant muscle wasting may have deceptively lower values relative to their degree of kidney impairment. SDMA is less affected by muscle mass but can be influenced by other factors. Single measurements provide a snapshot, and serial monitoring to establish trends is generally more informative. Hydration status significantly affects results, and values should ideally be assessed when the dog is adequately hydrated.

Urinalysis with urine protein assessment

Purpose: Evaluation of urine specific gravity assesses the kidneys' concentrating ability, while urine sediment examination can reveal active inflammation, infection, or crystal formation. The urine protein-to-creatinine ratio (UPC) quantifies protein loss through the kidneys, which is an important prognostic indicator and guides management decisions. Urine culture may be performed to exclude urinary tract infection, which can both cause and complicate kidney disease.
Considerations: Urine specific gravity varies with hydration status and recent water intake, so a single dilute sample must be interpreted in context. Proteinuria can be caused by conditions other than primary kidney disease, including urinary tract infection and inflammatory conditions, so the cause should be investigated before attributing it solely to CKD. Serial UPC measurements are more reliable than single values for assessing trends.

Blood pressure measurement

Purpose: Hypertension is a common complication of CKD in dogs and can accelerate kidney damage while also affecting the eyes, brain, and cardiovascular system. Regular blood pressure monitoring helps identify hypertension early and guides treatment decisions. Multiple readings are typically taken during a single visit to account for stress-related variation.
Considerations: Accurate blood pressure measurement in dogs requires an appropriate cuff size and a calm patient. Anxiety-related elevations can occur, and serial measurements over multiple visits may be needed to distinguish true hypertension from situational effects. The relationship between blood pressure and kidney disease progression means that identified hypertension generally warrants management.

Abdominal imaging (ultrasound and/or radiography)

Purpose: Abdominal ultrasound provides detailed information about kidney size, shape, internal architecture, and the presence of structural abnormalities such as cysts, stones, tumours, or obstructions. Comparing the size and appearance of the two kidneys can provide clues about the nature and chronicity of the disease. Radiography may complement ultrasound by identifying kidney stones or assessing overall kidney size.
Considerations: Imaging findings provide structural information but do not directly measure function. Small, irregular kidneys suggest chronic disease, while enlarged kidneys may suggest certain specific conditions. Normal-appearing kidneys on ultrasound do not exclude functional impairment. The decision to pursue imaging should consider whether findings are likely to change the management approach.

IRIS staging and sub-staging

Purpose: The International Renal Interest Society (IRIS) staging system classifies CKD into stages 1-4 based on fasting serum creatinine or SDMA levels, with sub-staging for proteinuria (based on UPC) and blood pressure. This standardised framework helps guide management decisions, monitoring frequency, and communication about disease severity. It also provides a basis for tracking progression over time.
Considerations: Staging should ideally be performed when the dog is clinically stable and adequately hydrated, as illness or dehydration can temporarily worsen values. The stage provides a framework but represents a continuum rather than discrete categories. Some dogs may move between stages over time, in either direction, depending on management and the course of their disease.

Options & trade-offs

Management of chronic kidney disease in dogs focuses on slowing disease progression, managing complications, and maintaining quality of life. The approach is typically multimodal and evolves over time as the disease stage changes and the individual dog's responses to different interventions become apparent.

Dietary management

Therapeutic kidney diets for dogs are formulated with modified levels of protein (sufficient quality but controlled quantity), restricted phosphorus, supplemented omega-3 fatty acids, and often enhanced potassium and B vitamins. These diets aim to reduce the kidney's workload, limit phosphorus-driven progression, and provide adequate nutrition without generating excessive waste products. The transition to a kidney diet is ideally made gradually over one to two weeks.

Trade-offs: Palatability can be a challenge, particularly in dogs with reduced appetite. Some dogs resist dietary changes or find kidney diets less appealing than their previous food. The modified protein levels, while beneficial for kidney preservation, must be balanced against maintaining adequate nutrition and muscle mass. Dogs with concurrent conditions may have competing dietary requirements that need to be reconciled. Starting dietary management earlier in the disease course appears to offer the most benefit.

Phosphorus control

Controlling serum phosphorus is a cornerstone of CKD management. Dietary phosphorus restriction is the initial approach, supplemented with intestinal phosphate binders given with meals if blood phosphorus remains elevated despite dietary control. Phosphate binders work by binding dietary phosphorus in the gastrointestinal tract, preventing its absorption. Options include aluminium hydroxide, calcium-based binders, lanthanum carbonate, and chitosan-based products.

Trade-offs: Phosphate binders must be given with every meal to be effective, which requires consistent owner compliance. Different binders have different palatability profiles, and some dogs may resist certain formulations. Aluminium-based binders carry a theoretical risk of aluminium accumulation with long-term use. Calcium-based binders may contribute to hypercalcaemia in some patients. Finding an effective, well-tolerated binder may require trying several options.

Fluid management

Maintaining adequate hydration is essential in CKD management. Encouraging oral water intake through providing multiple fresh water sources, adding water to food, or offering flavoured water can help. In dogs whose oral intake is insufficient to compensate for urinary losses, subcutaneous fluid administration at home may be used. Some dogs receive intermittent intravenous fluid therapy during periods of decompensation.

Trade-offs: Home subcutaneous fluid administration requires owner training and a cooperative patient. The frequency and volume of fluid supplementation must be tailored to the individual dog and monitored to avoid over-hydration, particularly in dogs with concurrent cardiac disease. The acceptability of home fluid therapy varies widely among owners and dogs, and it adds a regular time commitment to the management routine.

Management of complications

As CKD progresses, various complications may emerge requiring specific management. These can include anaemia (potentially managed with erythropoiesis-stimulating agents or iron supplementation), hypertension (antihypertensive medication), metabolic acidosis (oral bicarbonate supplementation), nausea (anti-emetics and gastroprotectants), and proteinuria (ACE inhibitors or angiotensin receptor blockers). The need for these interventions is guided by clinical findings and monitoring results.

Trade-offs: Each additional medication increases the complexity of the management regime and adds cost. Erythropoiesis-stimulating agents can be effective for anaemia but may trigger antibody formation that worsens the anaemia in rare cases. ACE inhibitors for proteinuria require careful monitoring of kidney values and blood pressure. Balancing multiple medications in an older dog that may have other concurrent conditions requires careful coordination and regular reassessment.

Monitoring and reassessment

Regular follow-up blood work, urinalysis, and blood pressure monitoring allow tracking of disease progression and guide adjustments to the management plan. The frequency of monitoring depends on the disease stage and stability, ranging from every few months in stable early disease to more frequent assessments during periods of change. Body weight, body condition, and clinical observations complement laboratory data in building an overall picture.

Trade-offs: Ongoing monitoring involves regular veterinary visits and associated costs. The challenge lies in monitoring frequently enough to detect meaningful changes without creating unnecessary burden. Results must be interpreted in context, as day-to-day variation in values can occur. Trends over multiple measurements are generally more informative than isolated values, requiring a longitudinal approach to data interpretation.

Common misconceptions

Misconception:

"Chronic kidney disease in dogs has the same course and characteristics as in cats"

Reality:

While the basic pathophysiology shares similarities, there are important differences between canine and feline CKD. Dogs are more likely to have identifiable underlying causes, the disease may present with different clinical emphases, and some management options differ between species. Certain medications commonly used in cats may not be appropriate or available for dogs, and dietary approaches may need modification. The two species also differ in their typical age of onset and breed predispositions.

Misconception:

"A dog with kidney disease cannot eat any protein"

Reality:

The approach to protein in canine CKD has evolved significantly. Current understanding emphasises the quality and digestibility of protein rather than severe restriction. Therapeutic kidney diets provide sufficient high-quality protein to maintain muscle mass and body condition while controlling the volume of nitrogenous waste generated. Excessive protein restriction can lead to muscle wasting, immune compromise, and reduced quality of life. The goal is controlled, high-quality protein intake rather than minimal protein intake.

Misconception:

"Elevated kidney values always mean the kidneys are failing"

Reality:

Kidney blood values can be elevated for many reasons beyond chronic progressive kidney disease. Dehydration, which is common during illness, can significantly elevate creatinine and BUN without reflecting permanent kidney damage. Certain medications, high-protein meals, and urinary obstruction can also affect results. The distinction between pre-renal, renal, and post-renal causes of elevated values is important, as is differentiating between acute and chronic changes. Serial measurements after addressing contributing factors provide a more accurate picture of true kidney function.

Chronic kidney disease in dogs is a condition where understanding develops gradually through monitoring and observation. Trends in blood values, body weight, appetite patterns, and hydration status provide more insight than any single measurement. Many dogs with CKD can maintain a good quality of life for extended periods, particularly when the condition is identified before clinical signs become advanced. The management approach typically evolves as the disease stage and the individual dog's needs become clearer, with periodic reassessment helping to guide adjustments over time.

Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS